Impact on oxidative stress of novel analogues of insulin in people with type 1 diabetes. Low- intervention clinical trial.

Trial Profile

Impact on oxidative stress of novel analogues of insulin in people with type 1 diabetes. Low- intervention clinical trial.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Nov 2016

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine (Primary) ; Insulin aspart; Insulin detemir; Insulin glulisine; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms INEOX
  • Most Recent Events

    • 11 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top